The CFO's sales following option exercises and the President's separate large sale create a cluster of open-market selling by senior leadership. While the dollar amount is modest relative to market cap, the absence of 10b5-1 plans and the concentration in a 5-day window warrant monitoring for any upcoming negative news or guidance changes.
Price Chart
Executive Summary
Moderna CFO James Mock sold $4.68M in open-market shares on September 10, 2026, following option exercises, while President Stephen Hoge sold $5.81M on September 14. The combined $8.48M in open-market sales by two top executives represents ~0.1% of market cap — modest in scale but notable for involving both the CFO and President in a concentrated window.
Key Financial Metrics
Key Facts
- CFO James Mock sold 34,836 shares total ($4.68M) on Sept 10, including 19,836 shares at $134.49 and 15,000 shares at $134.49
- Mock also exercised 19,836 derivative shares at $30.96 ($614K) and 19,836 at $0 (non-cash) on the same day
- President Stephen Hoge sold 40,300 shares at $144.13 for $5.81M on Sept 14
- Total open-market sales: $8.48M from two top executives within a 5-day window
- No 10b5-1 plan indicated for either sale — both are open-market transactions
Financial Impact
Sales of $8.48M represent ~0.1% of market cap — modest but concentrated among top executives
Risk Factors
- Insider selling by both CFO and President may signal management's view of overvaluation or upcoming headwinds
- No 10b5-1 plans disclosed — sales are discretionary and potentially opportunistic
- Historical bearish calls on MRNA have been incorrect, suggesting the stock may not react negatively to insider selling
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-MRNA-1789592250988 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | ANALYST-DOWNGRADE | $192.70 | awaiting T+1 | — | $207.97 (−7.92%) |
Sep 30, 2026 27d ago | 8-K | $192.57 $188.94 | ▼ −1.89% | ▼ −2.06% | $207.97 (+8.00%) |
Sep 30, 2026 27d ago | ANALYST-DOWNGRADE | — | awaiting T+1 | — | — |
Sep 16, 2026 5w ago | Insider Cluster | $158.07 $154.04 | ▲ +2.55% | ▲ +2.43% | $207.97 (−31.57%) |
Sep 3, 2026 7w ago | ANALYST-DOWNGRADE | $148.87 $145.55 | ▲ +2.23% | ▲ +1.84% | $207.97 (−39.70%) |
Aug 31, 2026 8w ago | Court Ruling | $154.27 $150.81 | ▲ +2.24% | ▲ +2.69% | $207.97 (−34.81%) |
Aug 25, 2026 9w ago | ANALYST-UPGRADE | $158.83 $149.66 | ▼ −5.77% | ▼ −5.80% | $207.97 (+30.94%) |
Aug 19, 2026 9w ago | ANALYST-UPGRADE | $174.38 $133.32 | ▼ −23.55% | ▼ −22.71% | $207.97 (+19.26%) |
Aug 5, 2026 11w ago | 144 | $56.26 $53.86 | ▲ +4.26% | ▲ +4.10% | $207.97 (−269.69%) |
Jul 31, 2026 12w ago | 8-K | $54.82 $55.08 | ▲ +0.48% | ▼ −0.93% | $207.97 (+279.37%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers